HER2 overexpression and amplification is present in a subset of ovarian mucinous carcinomas and can be targeted with trastuzumab therapy

Jessica N. McAlpine, Kimberly C. Wiegand, Russell Vang, Bridgett M. Ronnett, Anna Adamiak, Martin Köbel, Steve E. Kalloger, Kenneth D. Swenerton, David G. Huntsman, C. Blake Gilks, Dianne M. Miller

Research output: Contribution to journal › Article › peer-review

134 Scopus citations

Fingerprint

Dive into the research topics of 'HER2 overexpression and amplification is present in a subset of ovarian mucinous carcinomas and can be targeted with trastuzumab therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences